References
- Joseph JT, Baines LS, Morris MC, Jindal RM. Quality of life after kidney and pancreas transplantation. Am. J. Kidneyvgvt Dis.42, 431–445 (2003).
- Davies NM, Grinyo J, Heading R, Maes B, Meier-Kriesche HU, Oellerich M. Gastrointestinal side effects of mycophenolic acid in renal transplant patients, a reappraisal. Nephrol. Dial. Transplant.22(9), 2440–2448 (2007).
- Bunnapradist S, Ambühl PM. Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies. Clin. Transplant.22(6), 815–821 (2008).
- Machnicki G, Ricci JF, Brennan DC, Schnitzler MA. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients. Pharmacoeconomics26(11), 951–967 (2008).
- Hubner GI, Eismann R, Sziegoleit W. Relationship between mycophenolate mofetil side effects and mycophenolic acid plasma trough levels in renal transplant patients. Arzneimittelforschung50(10), 936–940 (2000).
- Mourad M, Malaise J, Chaib Eddour D et al. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clin. Chem.47(1), 88–94 (2001).
- Kaplan B. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil, association with clinical outcome. Curr. Med. Res. Opin.22(12), 2355–2364 (2006).
- Budde K, Glander P, Krämer BK et al. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus, clinical, pharmacokinetic, and pharmacodynamic outcomes. Transplantation83(4), 417–424 (2007).
- Ciancio G, Burke GW, Gaynor JJ et al. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin, one year follow-up. Transplantation86(1), 67–74 (2008).
- Pietruck F, Abbud-Filho M, Vathsala A, Massari PU, Po-Huang L, Nashan B. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable maintenance renal transplant patients, pooled results from three international, multicenter studies. Transplant. Proc.39(1), 103–108 (2007).
- Darji P, Vijayaraghavan R, Thiagarajan CM et al. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders. Transplant. Proc.40(7), 2262–2267 (2008).
- Sarkio S, Halme L, Kyllönen L, Salmela K. Severe gastrointestinal complications after 1,515 adult kidney transplantations. Transpl. Int.17(9), 505–510 (2004).
- Bunnapradist S, Neri L, Wong W et al. Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am. J. Kidney Dis.51(3), 478–486 (2008).